Politics

California’s Proposed Cannabis Fee Just Got Smaller, but is It Still Too Much for Medicine?

Published on June 14, 2016 · Last updated July 28, 2020

Amid vocal pushback, California lawmakers this week scaled back a proposed fee on medical cannabis purchases and added a way for low-income patients to dodge the added cost. But patient advocates, noting that other medical treatments aren’t subject to special taxes, argue that even the modified plan will make for an undue burden on patients in the state. 

Senate Bill 987, introduced by Sen. Mike McGuire, would have tacked a 15-percent “user fee” — effectively a tax — onto all cannabis purchases. But on Monday lawmakers amended the bill to bring the rate down to 10 percent and include an exemption for patients who obtain a state medical cannabis ID card and can prove their income is less than 200 percent of the federal poverty level

The changes would no doubt ease the financial impact on patients, but many are still concerned the costs are too steep. Even obtaining an ID card — generally not necessary for patients to purchase, grow, and consume cannabis — can cost hundreds of dollars (prices vary by county). 

 California Moving Quickly to Tax Medical Cannabis

The Assembly Revenue and Taxation Committee is set to consider the bill Monday afternoon. Advocates are calling on patients and other members of the public to write to the committee to oppose the fee. Signed letters sent by end of day Tuesday, according to Americans for Safe Access, will be included in next week’s committee analysis and report. 

Committee staff request that letters be sent by fax — yes that’s right, facsimile machine — to 916-319-2198.

 Behind the Big Ban: Why California Towns are Scrambling to Oust Dispensaries

Shop highly rated dispensaries near you

Showing you dispensaries near
See all dispensaries
Ben Adlin
Ben Adlin
Ben Adlin is a Seattle-based writer and editor who specializes in cannabis politics and law. He was a news editor for Leafly from 2015-2019. Follow him on Twitter: @badlin
View Ben Adlin's articles
Get good reads, local deals, and strain spotlights delivered right to your inbox.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.



Stay In Touch

Receive updates on new products, special offers, and industry news.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.

Leafly mobile app
Get high for less.
Download the Leafly app.
Download Leafly: Marijuana Reviews on the App Store
Download Leafly Marijuana Reviews on Google Play




* Statements made on this website have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. Information provided by this website or this company is not a substitute for individual medical advice.


© 2024 Leafly, LLC
Leafly and the Leafly logo are registered trademarks of Leafly, LLC. All Rights Reserved.